MedWatch

Interim Lundbeck CEO: A strong financial statement

The Danish drug group Lundbeck continues on its course towards the best annual result in the company’s history. This gives rise to pride for CFO and interim CEO Anders Götzsche, who recently presented his first financial statement in position as interim head of the Danish company.

Foto: Lundbeck/PR - Anders Götzsche, CFO Lundbeck

This week, Lundbeck ended the first nine months of the year by presenting a strong Q3 interim report.

This is according to the company’s interim CEO, CFO Anders Götzsche. Wednesday morning, he presented a quarterly financial statement, in which the Danish CSN group, for the third time this year, upgraded its guidance.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier